UCSF News
Campus News, Research
CIRM News
Campus News, Research
Previous immunotherapies like CAR T cells were designed to target glioblastoma cells, but were only effective in killing a portion of the cells – leaving some cancer cells behind, and allowing for tumor recurrence.
Research
Published by UCSF News
Research
The UCSF Brain Tumor Center is leading a new randomized, double-blind, placebo-controlled, phase 3 clinical trial of enzastaurin combined with temozolomide and radiatio
Research
This year, the Society for Neuro-Oncology recognizes UCSF researchers Aaron Diaz, PhD and Radhika Mathur, PhD with awards at their annual meeting.
Campus News, Research
Published today in Nature Communications, Raleigh and colleagues characterize the range of intratumor heterogeneity found in meningioma, identifying potential therapeutic targets.
Research
Published by Precision Oncology News
Patient Care, Research
Comprehensive analysis of a rare tumor type identifies pediatric bithalamic glioma as a distinct tumor entity with potential sensitivity to a genomically-guided treatment strategy.
Research
Researchers at UC San Francisco have discovered how PGAM1 – a protein expressed at high levels in many cancers – can contribute to tumor cells’ resistance to radiation therapy and chemotherapy.
Research
Published by i3 Health News & Perspectives
Patient Care, Research
Within the next few months, the UCSF Brain Tumor Center will begin recruiting for a multi-center clinical trial to evaluate AG-881 for treatment of recurrent IDH-mutant grade II glioma.
Research
Published by UCSF News
Patient Care, Research
In 2019, the UCSF Brain Tumor Center researchers focused on therapeutic targets for glioblastoma, immunotherapies, precision medicine clinical trials and more.
Research
Immunotherapy encompasses a range of strategies aimed at making cancer cells more recognizable and vulnerable to attack by the patient’s immune system.
Campus News, Patient Care, Research
UCSF researchers recently received a Translational Team Science Award from the U.S. Department of Defense to support their research on immunotherapy for pediatric brain tumors.
Research